Scientific Article
Exposing the Philip Morris-funded Foundation for a Smoke-Free World

Author
Tess Legg (email: legg@bath.ac.uk), Silvy Peeters, Phil Chamberlain and Anna B Gilmore
Citation
Legg, T., Peeters, S., Chamberlain, P. and Gilmore, A. (2019). The Philip Morris-funded Foundation for a Smoke-Free World: tax return sheds light on funding activities. The Lancet, 393(10190), pp.2487-2488.
  • Source
    The Lancet
  • Release date
    06/06/2019

The Philip Morris-funded Foundation for a Smoke-Free World: Tax Return Sheds Light on Funding Activities

Research correspondence

Summary

Introduction

In September, 2017, Philip Morris International, one of the world’s largest tobacco companies, set up the “Foundation for a Smoke-Free World”, with almost US $1 billion of funding over 12 years.

The Foundation claims to be an independent scientific body aiming to “accelerate an end to smoking”. Yet controversy has surrounded the Foundation since its inception; its claims of legitimacy and independence have been strongly disputed and WHO and hundreds of public health organisations globally have taken a strong stance in rejecting collaboration with the Foundation.

Until now, information concerning the research the Foundation is funding, and who has accepted its money, has been scant. This changed when the Foundation filed its 2018 tax return. The present analysis of this filing adds to mounting evidence that the Foundation should be seen neither as an independent organisation nor as a primarily scientific one, and suggests that it might be having difficulty convincing researchers and potential funders of its legitimacy and independence as a scientific body.

Key Findings

  • The Foundation is still funded solely by Philip Morris International with an $80 million annual donation.
  • The Foundation spent $6.46 million on research grants in 2018, $7.59 million on communications (the majority of which was spent on public relations organisations), and $7.03 million on staffing.
  • Greater expenditure on public relations than on research supports the growing consensus that the Foundation provides a key public relations function for Philip Morris International.
  • The Foundation claims to be independent but is contracting organisations with long-standing tobacco industry links, such as Ogilvy Public Relations Worldwide and Mercury Public Affairs.
  • Founder and Director, Riccardo Polosa of the upcoming Center of Excellence for the Acceleration of Harm Reduction (CoEHAR) at the University of Catania, Italy previously accepted a grant from Philip Morris International of nearly €1 million to investigate its heated tobacco products.
  • The Glasgow-based Centre for Substance Use Research, led by Neil McKeganey, has in recent years received funding from Philip Morris International and other tobacco industry actors.

Conclusion

Overall, these findings suggest that as it reaches its second anniversary, the Foundation might be failing. It is seemingly struggling both to recruit independent researchers and to spend its resources on much other than public relations.

In line with public rejections from Bloomberg Philanthropies and the Bill & Melinda Gates Foundation, no further funders have materialised. Furthermore, several key staff members left the Foundation in its first 21 months of operation.

Now, more than ever, we must reinforce the hitherto successful calls from WHO and the public health community to reject collaboration with the Foundation.”

Source Website: The Lancet